Moderna (MRNA) PT Raised to $38 at BofA Securities
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $58.07 -2.67%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Join SI Premium – FREE
BofA Securities analyst Alec Stranahan raised the price target on Moderna (NASDAQ: MRNA) to $38.00 (from $34.00) while maintaining a Underperform rating.
You May Also Be Interested In
- Freedom Broker Upgrades Halliburton (HAL) to Hold
- Crown Holdings (CCK) PT Raised to $135 at BMO Capital
- Moderna (MRNA) PT Raised to $67 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
